Intravenous lysine clonixinate for the acute treatment of severe migraine attacks: a double-blind, randomized, placebo-controlled study

Author： Krymchantowski A.V.   Silva M.T.T.  

Publisher： Elsevier

ISSN： 0011-393X

Source： Current Therapeutic Research, Vol.64, Iss.8, 2003-09, pp. : 505-513

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Double‐blind, placebo‐controlled study of HGF gene therapy in diabetic neuropathy

By  

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 5, 2015-05 ,pp. : 465-478

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities: Subanalysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial

By Kimball Alexa B.  

American Journal of Clinical Dermatology, Vol. 12, Iss. 1, 2011-02 ,pp. : 51-62

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Desloratadine in Adults with Chronic Idiopathic Urticaria: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

By Ortonne Jean-Paul  

American Journal of Clinical Dermatology, Vol. 8, Iss. 1, 2007-01 ,pp. : 37-42

Adis International

Access to resources Recommend Favorite

Probiotic Supplement Reduces Atopic Dermatitis in Preschool Children: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial

By Gerasimov Sergei V.  

American Journal of Clinical Dermatology, Vol. 11, Iss. 5, 2010-10 ,pp. : 351-361

Adis International

Access to resources Recommend Favorite

Triage and management of the pregnant hypertensive patient - a randomized, double-blind, placebo-controlled trial

By Kelley M.A.  

Journal of Nurse-Midwifery, Vol. 44, Iss. 6, 1999-11 ,pp. : 558-571

Elsevier

Access to resources Recommend Favorite